All GLP-1 medications from licensed 503A compounding pharmacies Browse Products
Sourcing and compounding
Quality language needs to be precise. Compounded medications can be legally prescribed, but they are not FDA-approved finished products. The useful question is which pharmacy pathway, testing documentation, and provider oversight apply to the actual prescription.
A 503A pharmacy typically compounds patient-specific prescriptions under state board oversight. A 503B outsourcing facility registers with the FDA and can make larger batches under stricter manufacturing rules. The right path depends on the prescription and medication.
Patients should be able to ask how the medication is sourced, whether the facility is licensed, and what documentation supports identity, potency, sterility, and lot-level quality.
Compounded medications are not the same as FDA-approved branded drugs. Trial outcomes from branded products should not be presented as guaranteed results for compounded formulations.
Direct answers
No. Compounded medications are not FDA-approved finished products and are not evaluated by the FDA for safety, effectiveness, or quality before marketing.
Ask whether the prescription is filled by a 503A pharmacy or 503B outsourcing facility, whether the pharmacy is licensed, and whether lot-level quality documentation is available.